445 related articles for article (PubMed ID: 10619267)
1. A comparison of melanin bleaching and azure blue counterstaining in the immunohistochemical diagnosis of malignant melanoma.
Kligora CJ; Fair KP; Clem MS; Patterson JW
Mod Pathol; 1999 Dec; 12(12):1143-7. PubMed ID: 10619267
[TBL] [Abstract][Full Text] [Related]
2. Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms.
Kamino H; Tam ST
J Cutan Pathol; 1991 Dec; 18(6):436-9. PubMed ID: 1723081
[TBL] [Abstract][Full Text] [Related]
3. The effect of melanin bleaching on immunohistochemical staining in heavily pigmented melanocytic neoplasms.
Orchard GE; Calonje E
Am J Dermatopathol; 1998 Aug; 20(4):357-61. PubMed ID: 9700373
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical techniques: the effect of melanin bleaching.
Foss AJ; Alexander RA; Jefferies LW; Lightman S
Br J Biomed Sci; 1995 Mar; 52(1):22-5. PubMed ID: 7549602
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical comparison between MiTF and MART-1 with Azure blue counterstaining in the setting of solar lentigo and melanoma in situ.
Hillesheim PB; Slone S; Kelley D; Malone J; Bahrami S
J Cutan Pathol; 2011 Jul; 38(7):565-9. PubMed ID: 21362015
[TBL] [Abstract][Full Text] [Related]
6. Heavily pigmented melanocytic neoplasms: comparison of two melanin-bleaching techniques and subsequent immunohistochemical staining.
Orchard GE
Br J Biomed Sci; 1999; 56(3):188-93. PubMed ID: 10824327
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Analysis of Immunohistochemistry in Melanoma Tumors.
Lilyquist J; White KAM; Lee RJ; Philips GK; Hughes CR; Torres SM
Medicine (Baltimore); 2017 Apr; 96(15):e6432. PubMed ID: 28403073
[TBL] [Abstract][Full Text] [Related]
8. Depigmentation of Melanin-containing Tissues Using Hypochlorous Acid to Enhance Hematoxylin-eosin and Immunohistochemical Staining.
Wang L; Wang G
Appl Immunohistochem Mol Morphol; 2024 Jan; 32(1):53-59. PubMed ID: 37855438
[TBL] [Abstract][Full Text] [Related]
9. Comparison of bleaching protocols utilizing hematoxylin and eosin stain and immunohistochemical proliferation marker MCM3 in pigmented melanomas.
Jordan T; Williams D; Criswell S; Wang Y
J Histotechnol; 2019 Dec; 42(4):177-182. PubMed ID: 31416403
[TBL] [Abstract][Full Text] [Related]
10. Melanophages reside in hypermelanotic, aberrantly glycosylated tumor areas and predict improved outcome in primary cutaneous malignant melanoma.
Handerson T; Berger A; Harigopol M; Rimm D; Nishigori C; Ueda M; Miyoshi E; Taniguchi N; Pawelek J
J Cutan Pathol; 2007 Sep; 34(9):679-86. PubMed ID: 17696914
[TBL] [Abstract][Full Text] [Related]
11. Semi-automated standardisation of melanin bleaching procedures of heavily pigmented melanocytic lesions for immunohistochemical analysis on an automated platform.
Orchard GE; Gabriel J; Shams M; Fernando P; Satoc J; Nwokie T; Ismail F; d'Amico C
Br J Biomed Sci; 2019 Oct; 76(4):172-177. PubMed ID: 31144600
[No Abstract] [Full Text] [Related]
12. The immunoalkaline phosphatase technique in immunohistochemistry: the effect of permanganate-oxalate melanin bleaching upon four final reaction products.
Alexander RA; Cree IA; Foss AJ
Br J Biomed Sci; 1996 Jun; 53(2):170-1. PubMed ID: 8757696
[TBL] [Abstract][Full Text] [Related]
13. Bleaching of melanin before image cytometry of the DNA content of pigmented skin tumors.
Talve LA; Collan YU; Alanen KA
Anal Quant Cytol Histol; 1995 Oct; 17(5):344-50. PubMed ID: 8534337
[TBL] [Abstract][Full Text] [Related]
14. Ultrarapid staining for cutaneous melanoma: study and protocol.
Davis DA; Kurtz KA; Robinson RA
Dermatol Surg; 2005 Jul; 31(7 Pt 1):753-6; discussion 756. PubMed ID: 16029700
[TBL] [Abstract][Full Text] [Related]
15. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluation of melanin bleaching using warm diluted hydrogen peroxide for histopathological analysis.
Momose M; Ota H; Hayama M
Pathol Int; 2011 Jun; 61(6):345-50. PubMed ID: 21615609
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
Kopera D; Hohenleutner U; Stolz W; Landthaler M
Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
[TBL] [Abstract][Full Text] [Related]
18. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
[TBL] [Abstract][Full Text] [Related]
19. Immunostaining for MART-1 in the interpretation of problematic intra-epidermal pigmented lesions.
Wiltz KL; Qureshi H; Patterson JW; Mayes DC; Wick MR
J Cutan Pathol; 2007 Aug; 34(8):601-5. PubMed ID: 17640229
[TBL] [Abstract][Full Text] [Related]
20. Method of melanin bleaching in MIB1-Ki67 immunostaining of pigmented lesions: A quantitative evaluation in malignant melanomas.
Li LX; Crotty KA; Kril JJ; Palmer AA; McCarthy SW
Histochem J; 1999 Apr; 31(4):237-40. PubMed ID: 10447065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
